Clinical Research Directory

Inclusion Criteria: * Adults between 18-99, English or Spanish speaking * ≥8 weeks of laryngeal symptoms (dysphonia, throat clearing, cough, globus, and/or sore throat) * Current use of double daily dose acid suppression therapy (ex. omeprazole 40mg, omeprazole 20mg and famotidine 20mg) * Laryngoscopic exam prior to screening with current symptoms * At least 1 of the following: * Elevated reflux testing * Findings on upper endoscopy that are consistent with pathologic GERD * Fasting pepsin analysis result of ≥25 ng/mL within 4 months of enrollment (12 months if treatment plan has not changed) \*testing allowed at enrollment if not previously obtained Exclusion Criteria: * Prior use of Reflux Band (UES Compression Device) * Sino-pulmonary conditions (such as asthma, COPD, post-nasal drip, heavy voice use) as primary etiology of laryngeal symptoms as deemed by treating gastroenterologist and / or laryngologist * Laryngeal mass or lesion on laryngoscopy * Pregnant or breastfeeding * Unable to consent in English or Spanish * Imprisoned * Patients with a prior foregut surgery * Patients with a known achalasia diagnosis * Inability to fast for 4 hours * Active tobacco use * Supplemental oxygen use * Contraindication to UES Compression Device manufacturer guidelines: * Patients with implants or implant parts that reside in the area where Reflux Band is applied: implanted pacemarker, implanted cardioverter defibrillator (ICD), vagus nerve stimulator (VNS), or other such devices implanted in the neck * Patients diagnosed with glaucoma. * Patients who had a malignancy of the neck, including neck surgery. * Patients that may have an altered mental status including due to the use of sedative drugs or narcotics. * Patients with carotid artery disease, uncontrolled thyroid disease, a history of cerebrovascular disease, or connective tissue disorder of Marfan's Syndrome or Ehlers-Danlos Syndrome * Patients who use nocturnal NIV machines such as CPAP or BiPAP.